These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. [New applications of erythropoietin in cardiovascular disease: from haematopoiesis to cardiac protection]. van der Meer P; van Veldhuisen DJ Ned Tijdschr Geneeskd; 2008 Apr; 152(16):923-7. PubMed ID: 18561787 [TBL] [Abstract][Full Text] [Related]
30. Natriuretic peptides and heart failure in the patient with chronic kidney disease: a review of current evidence. Dhar S; Pressman GS; Subramanian S; Kaul S; Gollamudi S; Bloom EJ; Figueredo VM Postgrad Med J; 2009 Jun; 85(1004):299-302. PubMed ID: 19528304 [TBL] [Abstract][Full Text] [Related]
31. Cardiac fibroblasts: at the heart of myocardial remodeling. Porter KE; Turner NA Pharmacol Ther; 2009 Aug; 123(2):255-78. PubMed ID: 19460403 [TBL] [Abstract][Full Text] [Related]
32. Natriuretic peptides in heart failure: empathizing with the sobbing heart.. Narula J; Young JB Heart Fail Clin; 2006 Jul; 2(3):xi-xiii. PubMed ID: 17386893 [No Abstract] [Full Text] [Related]
33. Effect of long-term B-type natriuretic peptide treatment on left ventricular remodeling and function after myocardial infarction in rats. He J; Chen Y; Huang Y; Yao F; Wu Z; Chen S; Wang L; Xiao P; Dai G; Meng R; Zhang C; Tang L; Huang Y; Li Z Eur J Pharmacol; 2009 Jan; 602(1):132-7. PubMed ID: 19027731 [TBL] [Abstract][Full Text] [Related]
34. New insights into the role of natriuretic peptides in the regulation of apoptosis in cardiovascular system. Gao P; Huang L Saudi Med J; 2009 May; 30(5):595-604. PubMed ID: 19417955 [TBL] [Abstract][Full Text] [Related]